|
Name |
Sabinene hydrate
|
Molecular Formula | C10H18O | |
IUPAC Name* |
2-methyl-5-propan-2-ylbicyclo[3.1.0]hexan-2-ol
|
|
SMILES |
CC(C)C12CCC(C1C2)(C)O
|
|
InChI |
InChI=1S/C10H18O/c1-7(2)10-5-4-9(3,11)8(10)6-10/h7-8,11H,4-6H2,1-3H3
|
|
InChIKey |
KXSDPILWMGFJMM-UHFFFAOYSA-N
|
|
Synonyms |
Sabinene hydrate; 4-Thujanol; 546-79-2; 2-methyl-5-propan-2-ylbicyclo[3.1.0]hexan-2-ol; 5-Isopropyl-2-methylbicyclo[3.1.0]hexan-2-ol; Bicyclo[3.1.0]hexan-2-ol, 2-methyl-5-(1-methylethyl)-; FEMA No. 3239; cis-4-thujanol; Bicyclo(3.1.0)hexan-2-ol, 2-methyl-5-(1-methylethyl)-; cis-Sabinenhydrate; cis-Sabinene hydrate; Sabinene hydrate, cis; 4-Thujanol (natural); 4-methyl-1-propan-2-ylbicyclo[3.1.0]hexan-4-ol; cis-Sabinenehydrate; cis-Sabinene hydrate (cis for IP vs Me); EINECS 208-911-7; (Z)-Sabinene hydrate; Sabinene hydrate trans (trans for IP vs. OH); trans-Sabinene hydrate (trans for IP vs. OH); sabinene hydrate (cis-); (1R,2S,5S)-5-Isopropyl-2-methylbicyclo[3.1.0]hexan-2-ol; SCHEMBL438844; 2-Methyl-5-(1-methylethyl)bicyclo(3.1.0)hexan-2-ol; CHEBI:16377; DTXSID40862164; (1.alpha.,2.beta.,5.alpha.)-2-Methyl-5-(1-methylethyl)bicyclo(3.1.0)hexan-2-ol; 5-Isopropyl-2-methylbicyclo[3.1.0]hexan-2-ol-, (1.alpha.,2.beta.,5.alpha.)-; 4-Thujanol 100 microg/mL in Acetonitrile; DB-052630; FT-0632362; FT-0778147; Q27101876
|
|
CAS | 546-79-2 | |
PubChem CID | 62367 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 154.25 | ALogp: | 2.1 |
HBD: | 1 | HBA: | 1 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 20.2 | Aromatic Rings: | 2 |
Heavy Atoms: | 11 | QED Weighted: | 0.615 |
Caco-2 Permeability: | -4.329 | MDCK Permeability: | 0.00002340 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.009 | 20% Bioavailability (F20%): | 0.023 |
30% Bioavailability (F30%): | 0.224 |
Blood-Brain-Barrier Penetration (BBB): | 0.778 | Plasma Protein Binding (PPB): | 71.10% |
Volume Distribution (VD): | 1.222 | Fu: | 36.26% |
CYP1A2-inhibitor: | 0.069 | CYP1A2-substrate: | 0.571 |
CYP2C19-inhibitor: | 0.063 | CYP2C19-substrate: | 0.904 |
CYP2C9-inhibitor: | 0.051 | CYP2C9-substrate: | 0.229 |
CYP2D6-inhibitor: | 0.016 | CYP2D6-substrate: | 0.365 |
CYP3A4-inhibitor: | 0.155 | CYP3A4-substrate: | 0.299 |
Clearance (CL): | 14.208 | Half-life (T1/2): | 0.389 |
hERG Blockers: | 0.014 | Human Hepatotoxicity (H-HT): | 0.084 |
Drug-inuced Liver Injury (DILI): | 0.039 | AMES Toxicity: | 0.033 |
Rat Oral Acute Toxicity: | 0.076 | Maximum Recommended Daily Dose: | 0.049 |
Skin Sensitization: | 0.14 | Carcinogencity: | 0.123 |
Eye Corrosion: | 0.064 | Eye Irritation: | 0.958 |
Respiratory Toxicity: | 0.112 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002232 | 1.000 | D07QKN | 0.271 | ||||
ENC005252 | 0.512 | D04CSZ | 0.234 | ||||
ENC001814 | 0.381 | D0H1QY | 0.234 | ||||
ENC001292 | 0.381 | D01CKY | 0.210 | ||||
ENC000528 | 0.366 | D0V8HA | 0.196 | ||||
ENC003100 | 0.358 | D0L2LS | 0.190 | ||||
ENC001893 | 0.358 | D0U3GL | 0.184 | ||||
ENC003098 | 0.349 | D0Z1XD | 0.184 | ||||
ENC002220 | 0.349 | D01JEU | 0.182 | ||||
ENC000331 | 0.341 | D04ATM | 0.181 |